PainChek Limited (ASX:PCK)
Australia
· Delayed Price · Currency is AUD 0.175
+0.010 (6.06%)
At close: Mar 6, 2026
PainChek Revenue
PainChek had revenue of 1.73M AUD in the half year ending December 31, 2025, with 32.96% growth. This brings the company's revenue in the last twelve months to 3.44M, up 13.60% year-over-year. In the fiscal year ending June 30, 2025, PainChek had annual revenue of 3.36M with 25.84% growth.
Revenue (ttm)
3.44M
Revenue Growth
+13.60%
P/S Ratio
10.64
Revenue / Employee
n/a
Employees
n/a
Market Cap
36.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.36M | 690.49K | 25.84% |
| Jun 30, 2024 | 2.67M | 716.07K | 36.61% |
| Jun 30, 2023 | 1.96M | 961.72K | 96.74% |
| Jun 30, 2022 | 994.15K | 760.26K | 325.05% |
| Jun 30, 2021 | 233.89K | -63.29K | -21.30% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Emyria | 2.29M |
| Vitasora Health | 5.01M |
| Beamtree Holdings | 28.90M |
| TrivarX | -95.36K |
| ImExHS | 28.97M |
| Resonance Health | 13.84M |
| Mach7 Technologies | 29.70M |
| PharmX Technologies | 7.65M |
PainChek News
- 4 weeks ago - Painchek Ltd (ASX:PCK) (H1 2026) Earnings Call Highlights: Strategic US Expansion and Strong ... - GuruFocus
- 4 weeks ago - Half Year 2026 PainChek Ltd Earnings Call Transcript - GuruFocus